XML 29 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Series A Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In-Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2017 $ 5,000         $ (4,564) $ (4,564)
Balance at beginning (in shares) at Dec. 31, 2017 5,000,000   226,400        
Issuance of treasury stock as founders’ stock (in shares)     75,467 (75,467)      
Net loss and comprehensive loss           (421) (421)
Balance at ending at Mar. 31, 2018 $ 5,000         (4,985) (4,985)
Balance at ending (in shares) at Mar. 31, 2018 5,000,000   226,400        
Balance at beginning at Dec. 31, 2017 $ 5,000         (4,564) (4,564)
Balance at beginning (in shares) at Dec. 31, 2017 5,000,000   226,400        
Net loss and comprehensive loss             (20,242)
Balance at ending at Sep. 30, 2018 $ 14,108         (25,093) (25,093)
Balance at ending (in shares) at Sep. 30, 2018 22,653,333   226,400        
Repurchase of founders’ stock (in shares)     (75,467) 75,467      
Balance at beginning at Mar. 31, 2018 $ 5,000         (4,985) (4,985)
Balance at beginning (in shares) at Mar. 31, 2018 5,000,000   226,400        
Issuance of stock   $ 8,787          
Issuance of stock (in shares)   17,653,333          
Accretion of redeemable convertible preferred stock to redemption value $ 70         70 70
Net loss and comprehensive loss           (8,673) (8,673)
Balance at ending at Jun. 30, 2018 $ 13,857         (13,728) (13,728)
Balance at ending (in shares) at Jun. 30, 2018 22,653,333   226,400        
Stock-based compensation expense         $ 34   34
Accretion of redeemable convertible preferred stock to redemption value         34    
Accretion of redeemable convertible preferred stock to redemption value $ 251         217 251
Net loss and comprehensive loss           (11,148) (11,148)
Balance at ending at Sep. 30, 2018 $ 14,108         (25,093) (25,093)
Balance at ending (in shares) at Sep. 30, 2018 22,653,333   226,400        
Balance at beginning at Dec. 31, 2018 $ 124,728       36,646 (86,565) (49,919)
Balance at beginning (in shares) at Dec. 31, 2018 64,730,410   238,986        
Stock-based compensation expense         215   215
Net loss and comprehensive loss           (5,362) (5,362)
Balance at ending at Mar. 31, 2019 $ 124,728       36,861 (91,927) (55,066)
Balance at ending (in shares) at Mar. 31, 2019 64,730,410   238,986        
Balance at beginning at Dec. 31, 2018 $ 124,728       36,646 (86,565) (49,919)
Balance at beginning (in shares) at Dec. 31, 2018 64,730,410   238,986        
Conversion of convertible preferred stock into common stock upon closing of initial public offering             $ 124,728
Issuance of restricted common stock upon early exercise of stock options (in shares)     383,320        
Exercise of stock options (in shares)             651,031
Net loss and comprehensive loss             $ (28,144)
Balance at ending at Sep. 30, 2019     $ 3   258,090 (114,709) 143,384
Balance at ending (in shares) at Sep. 30, 2019     28,558,653        
Balance at beginning at Mar. 31, 2019 $ 124,728       36,861 (91,927) (55,066)
Balance at beginning (in shares) at Mar. 31, 2019 64,730,410   238,986        
Conversion of convertible preferred stock into common stock upon closing of initial public offering $ (124,728)   $ 2   124,726   124,728
Conversion of convertible preferred stock into common stock upon closing of initial public offering (in shares) (64,730,410)   21,056,136        
Issuance of stock     $ 1   95,452   95,453
Issuance of stock (in shares)     6,612,500        
Issuance of restricted common stock upon early exercise of stock options (in shares)     487,933        
Exercise of stock options         100   100
Exercise of stock options (in shares)     159,824        
Stock-based compensation expense         402   402
Net loss and comprehensive loss           (7,228) (7,228)
Balance at ending at Jun. 30, 2019     $ 3   257,541 (99,155) 158,389
Balance at ending (in shares) at Jun. 30, 2019     28,555,379        
Vesting of restricted common stock         66   66
Issuance of restricted common stock upon early exercise of stock options (in shares)     3,274        
Stock-based compensation expense         483   483
Net loss and comprehensive loss           (15,554) (15,554)
Balance at ending at Sep. 30, 2019     $ 3   $ 258,090 $ (114,709) $ 143,384
Balance at ending (in shares) at Sep. 30, 2019     28,558,653